A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Novel Host-Mimetic, Virus Killing Technology Platform SHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum
StockNews.com started coverage on shares of NanoViricides (NYSE:NNVC – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a sell rating on the stock. NanoViricides Stock Performance Shares of NNVC stock opened at $2.23 on Friday. The company’s fifty day simple moving average is $1.46 and its 200-day simple […]
Investment analysts at StockNews.com started coverage on shares of NanoViricides (NYSE:NNVC – Get Free Report) in a report released on Saturday. The firm set a “sell” rating on the stock. NanoViricides Price Performance NNVC opened at $2.23 on Friday. The firm’s 50 day moving average is $1.44 and its 200-day moving average is $1.24. NanoViricides […]
Stock analysts at StockNews.com assumed coverage on shares of NanoViricides (NYSE:NNVC – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the stock. NanoViricides Price Performance Shares of NYSE NNVC opened at $2.23 on Friday. NanoViricides has a 12 month low of $1.00 and a 12 month […]